CORRECTION - IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 22, 2019 – Conference Call to...
March 18 2019 - 05:35PM
In a release issued under a similar headline earlier today by
IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT), please
note that the financial results will be reported on March 22nd,
after market hours, and that the conference call will be on March
25th, before market open, at 8:00 AM EDT.
The corrected release follows:
IntelGenx Technologies Corp. (TSX
VENTURE:IGX)(OTCQX:IGXT) today announced that it will release its
fourth quarter and full year 2018 financial results after
market close on March 22, 2019.
An associated conference call will be hosted by
Dr. Horst G. Zerbe, President and Chief Executive Officer, and
Mr. Andre Godin, Executive Vice-President and Chief Financial
Officer, on March 25, 2019 to discuss the results and provide a
business update. Details of the conference call and webcast are
below:
Date: Monday, March 25,
2019
Time: 8:00 a.m. EDT
Conference dial-in: (833)
231-8269
International
dial-in: (647) 689-4114
Conference ID: 1297963
Webcast
Registration: Click here
Following the live call, a replay will be
available on the Company's website, www.intelgenx.com, under
"Investor Relations".
About IntelGenx:
Established in 2003, IntelGenx is a leading oral
drug delivery company primarily focused on the development and
manufacturing of innovative pharmaceutical oral films based on its
proprietary VersaFilm™ technology platform.
IntelGenx's highly skilled team provides
comprehensive pharmaceuticals services to pharmaceutical partners,
including R&D, analytical method development, clinical
monitoring, IP and regulatory services. IntelGenx's
state-of-the-art manufacturing facility, established for the
VersaFilm™ technology platform, supports lab-scale to pilot and
commercial-scale production, offering full service capabilities to
its clients. More information about the company can be found at
www.intelgenx.com.
Each of the TSX Venture Exchange and OTCQX has
neither approved nor disapproved the contents of this press
release. Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Source: IntelGenx Technologies Corp.
For more information, please contact:
Stephen Kilmer
Investor Relations
(514) 331-7440 ext 232
stephen@intelgenx.com
Or
Andre Godin, CPA, CA
Executive Vice-President and CFO
IntelGenx Corp.
(514) 331-7440 ext 203
andre@intelgenx.com
Intelgenx Technologies (TSXV:IGX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Intelgenx Technologies (TSXV:IGX)
Historical Stock Chart
From Mar 2023 to Mar 2024